Pelish Henry E. 4
4 · Nuvalent, Inc. · Filed Jul 10, 2026
Research Summary
AI-generated summary of this filing
Nuvalent (NUVL) CSO Henry Pelish Sells 2,111 Shares
What Happened Henry E. Pelish, Chief Scientific Officer of Nuvalent, reported an open-market sale of 2,111 shares on July 9, 2026. The shares were sold at $123.81 per share, generating gross proceeds of approximately $261,363. This transaction is coded as a sale (S) and was executed to cover taxes related to previously granted equity awards.
Key Details
- Transaction date: 2026-07-09; Sale price: $123.81 per share; Shares sold: 2,111; Proceeds: ~$261,363.
- Shares owned after the transaction: not specified in the filing.
- Footnote: Sale effected pursuant to a durable Rule 10b5-1 sell-to-cover instruction entered Dec 6, 2023 to satisfy tax withholding on vested awards.
- Filing date: 2026-07-10 (filed the business day after the transaction), so appears timely.
Context This was a routine sell-to-cover under a pre-existing 10b5-1 plan to satisfy tax obligations from vested equity, not an open-ended directional trade. Such tax-withholding sales are common and do not necessarily indicate the insider's view on the company's prospects.
Insider Transaction Report
Form 4
Nuvalent, Inc.NUVL
Pelish Henry E.
Chief Scientific Officer
Transactions
- Sale
Class A Common Stock
[F1]2026-07-09$123.81/sh−2,111$261,363→ 63,493 total
Footnotes (1)
- [F1]The sale was effected pursuant to a durable Rule 10b5-1 sell-to-cover instruction letter entered into on December 6, 2023 to satisfy the reporting person's tax withholding obligations upon the vesting of previously granted equity awards.
Signature
/s/ Nathan N. McConarty, attorney-in-fact|2026-07-10